We are live on ! Find out more
NTGN

Neon Therapeutics, Inc. Common Stock
NTGN

Delisted

NTGN was delisted on the 5th of May, 2020.

Back to rankings

0 hedge funds and large institutions have $0 invested in Neon Therapeutics, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 43 → 0 (-43)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less capital invested

Capital invested by funds: $39.9M → $0 (-$39.9M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 43

Holders
–
Holders Change
-43
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
43
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
TGI
TRV GP III
Massachusetts
-$25.7M
2
AC
Armistice Capital
New York
-$2.77M
3
BlackRock
BlackRock
New York
-$2.18M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$1.9M
5
AC
Athanor Capital
New York
-$1.45M
Name Holding Trade Value Shares
Change 		Change in
Stake
TGI
1
TRV GP III
Massachusetts
– -$25.7M -9,741,636 Closed
AC
2
Armistice Capital
New York
– -$2.77M -1,050,000 Closed
BlackRock
3
BlackRock
New York
– -$2.18M -825,810 Closed
Vanguard Group
4
Vanguard Group
Pennsylvania
– -$1.9M -718,689 Closed
AC
5
Athanor Capital
New York
– -$1.45M -547,651 Closed
HMC
6
Harvard Management Company
Massachusetts
– -$1.33M -505,871 Closed
MS
7
Maven Securities
Jersey
– -$1.01M -381,150 Closed
State Street
8
State Street
Massachusetts
– -$728K -275,605 Closed
Geode Capital Management
9
Geode Capital Management
Massachusetts
– -$559K -212,119 Closed
Northern Trust
10
Northern Trust
Illinois
– -$445K -168,533 Closed
MGIA
11
Moneta Group Investment Advisors
Missouri
– -$271K -102,652 Closed
Acadian Asset Management
12
Acadian Asset Management
Massachusetts
– -$251K -94,908 Closed
Bank of New York Mellon
13
Bank of New York Mellon
New York
– -$184K -69,630 Closed
Morgan Stanley
14
Morgan Stanley
New York
– -$156K -58,904 Closed
Renaissance Technologies
15
Renaissance Technologies
New York
– -$138K -52,105 Closed
N
16
Nuveen
North Carolina
– -$114K -43,182 Closed
Deutsche Bank
17
Deutsche Bank
Germany
– -$101K -38,276 Closed
HSBC Holdings
18
HSBC Holdings
United Kingdom
– -$84K -31,631 Closed
Charles Schwab
19
Charles Schwab
California
– -$81K -30,308 Closed
California State Teachers Retirement System (CalSTRS)
20
California State Teachers Retirement System (CalSTRS)
California
– -$60K -22,899 Closed
RhumbLine Advisers
21
RhumbLine Advisers
Massachusetts
– -$57K -21,720 Closed
TB
22
Terril Brothers
Missouri
– -$51K -19,300 Closed
Wells Fargo
23
Wells Fargo
California
– -$45K -17,024 Closed
Bank of America
24
Bank of America
North Carolina
– -$41K -15,849 Closed
UBS Group
25
UBS Group
Switzerland
– -$42K -15,759 Closed
1
2

NTGN Hedge Fund Activity: Q2 2020 in Review

0 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Neon Therapeutics, Inc. Common Stock (NTGN) for Q2 2020, worth a combined $0 — down 100% from $39.9M a quarter earlier.

Sellers outnumbered buyers: 43 funds closed out of NTGN and 0 opened new positions — a net loss of 43 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was TRV GP III, exiting entirely with an estimated $25.7M sold.

  • 0 institutional investors held Neon Therapeutics, Inc. Common Stock (NTGN) as of Q2 2020, down from 43 in Q1 2020.
  • Funds reported $0 of Neon Therapeutics, Inc. Common Stock stock for Q2 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Neon Therapeutics, Inc. Common Stock positions in Q2 2020 and 43 closed out, a net change of -43 holders.
  • The largest Neon Therapeutics, Inc. Common Stock seller in Q2 2020 was TRV GP III, an estimated $25.7M sold.

Based on aggregated 13F filings for Q2 2020.